Ja Hish

X + Me=Why, Lives for tabouli from the mountain. Question- Why are people so angry?

[Ja Hish @yachmod]

@ManniloTrader Just make sure the Joker and the Penguin don’t show up!

[Ja Hish @yachmod]

@AudonThiggy Seems like a logical step and would probably be a great partnership with great complementary therapies.

[Ja Hish @yachmod]

@bullishbruk You know Bullish, everything the good doctor said may very well be true but it also takes investors and what they rely on, like headlines and social media, as small as that seems to him, to bring drugs to market.

[Ja Hish @yachmod]

@HMSBeagle487064 Not sure but XBI was down 4.39% today

[Ja Hish @yachmod]

$SRPT Anybody attending the Shareholder meeting on Thursday to see how many shares will be given away? Maybe will raffle off a few to retail holders. Took my packet to my “proxytologist” & he rolled it up & said, “Let me look up there to see into the future”. Guess what he saw.

[Ja Hish @yachmod]

@Hall8Jack @christine_leola The ramping up of lower volume dosing sites & talking to community and physicians about risk/benefits. DI mentioned it in May 2025 before wheels fell off. I guess Dallen or whatever his name is was feeding him a line of BS on volume cause he was fired shortly after. Conjecture.

[Ja Hish @yachmod]

$SRPT So Edgewise’s DMD phase II business is worth $2.4B? Hmmm. Worth $600M more than @Sarepta MC with 4 DMD drugs and $ARWR licensing deals. Make this make sense. Management, you got any deals cooking?

[Ja Hish @yachmod]

@christine_leola @Sarepta Really mind-boggling. Heck the $SRPT MC is close to what their annual revenue will be with slight uptick and growing ex-US contributions. Will see how Patrick Moss’s project goes and if they have been extremely conservative in setting expectations. The $ARWR agreement is gravy.

[Ja Hish @yachmod]

$SRPT TRIGGER WARNING Had a bit of @Sarepta withdrawal this morning and bought more to add to warehouse.
Safe Harbor: Past performance does not guarantee future outcomes. If you experience anal leakage due to purchasing-STOP!

[Ja Hish @yachmod]

@haodi_luo @Sarepta Yep, I am telling you they could cure stupid and it would go down.

[Ja Hish @yachmod]

$SRPT Hallelujah! @Sarepta mgmt gonna participate in a couple of upcoming investor conferences!

https://t.co/APPJjxVtyr

[Ja Hish @yachmod]

$ABVX You wonder why biotech industries in western countries are being demolished by China. It is not just regulatory issues, there are no financial/legal protections for “false” narratives created by special interests. No skin in this one but shameful on good news.

[Ja Hish @yachmod]

Wouldn’t mind seeing a few more get investigated and get a knock on the door by the @FBI at 5 AM.
@SECGov @FINRA say shorting has benefits for the market. Right! Mainly a way for the movers to shake the avg investor down!

$SRPT $IBRX

[Laura Loomer @LauraLoomer]

BREAKING:

Andrew Left, one of the world’s most notorious short sellers, has been found GUILTY of 12 out of 16 counts of securities fraud by a US federal jury.

The landmark trial exposed how he used social media to manipulate stock prices for profit.

The era of short-and-distort schemes is cracking. Justice has been served.

[Ja Hish @yachmod]

@MarcJacksonLA Thank you for sharing!

[Ja Hish @yachmod]

@Corybory3218 @US_FDA @RobertKennedyJr @FDACBER @Sarepta Absolutely! @Sarepta was in do or die situation caused by circumstances but @US_FDA & @FDACBER unfairly used as leverage to have label change when there was no data to support a “black box” change for ambulatory nor kaboshing the whole LGMD program. Shameful! $SRPT

[Ja Hish @yachmod]

$SRPT Call for @US_FDA @RobertKennedyJr to rescind the “black box” label for Elevidys ambulatory patients. Was just meat thrown at a hostile @FDACBER hostile bully ex-chief. Also reinstate the platform status for the @Sarepta LGMD vector while you’re at it!

[Ja Hish @yachmod]

$IBRX Why the disdain for a proven safe therapy by so-called biotech media & certain medical people? Anktiva is a wonderful drug boosting immune system for vulnerable. Especially as a 2nd line treatment for certain diseases. What drives sentiment to not want or support this?

[Ja Hish @yachmod]

$IBRX @ImmunityBio is fighting City Hall. Going to be a tough nut to crack given the vested interests. Obviously the short interest is backed by some powerful entities. All the more reason to work with ex-US countries. Interesting how revenues for qtr will be to fund this battle.

[Ja Hish @yachmod]

@Deepvalue69420 @bullishbruk @kacdnp91 Not sure why they dump @DrPatrick in “pro-vaccine” bucket. He was neither. He wanted vaccines to focus on T cell immunity & not antibodies. Amazing how polarized medical community is now. In past times doctors/medical field did not get on a platform & disrespect colleagues. $IBRX

[Ja Hish @yachmod]

@JTLonsdale Yes, and how about incentives in markets for startups and a little defense for them from the vulturous shorts that know 90% will ultimately not be successful and are killed before they even have a chance to prove themselves.